Label: OPTASE- white petrolatum, lanolin ointment

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated December 30, 2022

If you are a consumer or patient please visit this version.

  • Active Ingredients

    active

  • Keep Out of Reach of Children

    Children

  • Purpose

    Purpose

  • Inactive Ingredients

    Inactive

  • Directions

    Directions

  • Warnings

    Warnings

  • Uses

    Uses

  • INSTRUCTIONS FOR USE

    Insert

  • Instructions

    Insert

  • Principal Display Panel

    PDP

  • INGREDIENTS AND APPEARANCE
    OPTASE 
    white petrolatum, lanolin ointment
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72972-003
    Route of AdministrationOPHTHALMIC
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PETROLATUM (UNII: 4T6H12BN9U) (PETROLATUM - UNII:4T6H12BN9U) PETROLATUM0.9 g  in 1 g
    LANOLIN (UNII: 7EV65EAW6H) (LANOLIN - UNII:7EV65EAW6H) LANOLIN0.06 g  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    LIGHT MINERAL OIL (UNII: N6K5787QVP)  
    VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72972-003-011 in 1 BOX05/05/2021
    15 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalM01805/05/2021
    Labeler - Scope Health Inc (116778693)
    Registrant - Regulatory Matters Consulting (080711165)